The gut metagenomics and metabolomics signature in patients with inflammatory bowel disease

Inflammatory bowel disease (IBD), a chronic gut immune dysregulation and dysbiosis condition is rapidly increasing in global incidence. Regardless, there is a lack of ideal diagnostic markers, while conventional treatment provides scarce desired results, thus, the exploration for better options. Cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xinwei, Ocansey, Dickson Kofi Wiredu, Hang, Sanhua, Wang, Bo, Amoah, Samuel, Yi, Chengxue, Zhang, Xu, Liu, Lianqin, Mao, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215062/
https://www.ncbi.nlm.nih.gov/pubmed/35729658
http://dx.doi.org/10.1186/s13099-022-00499-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215062/
https://www.ncbi.nlm.nih.gov/pubmed/35729658
http://dx.doi.org/10.1186/s13099-022-00499-9

Ejemplares similares